The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company, with ...

Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

The recent approval enables Zydus Lifesciences to produce and sell Apalutamide Tablets, 60 mg (a generic equivalent of Erleada) in the United States. Apalutamide is an androgen receptor inhibitor ...

Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...